Inhibition of RIP1 or MLKL decreases morbidity and mortality during <i>S</i>. <i>marcescens</i> hemorrhagic pneumonia. by Norberto González-Juarbe (836747)

Blockage of TF expression in PC14PE6/AS2 cells decreased ability of vascular permeability and ascites formation. by Hsuan-Heng Yeh (463876)

Treatment with BMP-7 decreases expression of M1 macrophage marker, iNOS, as well as pro-inflammatory cytokines. by Crystal Rocher (500661)

“…Scale bar  = 50 µm. Histogram <b>B</b> shows quantitative analysis of the percentage of cells expressing iNOS with a significant decrease in the control and ACM+BMP7 and groups and a significant increase in the ACM and ACM+BMP7+Foll groups; n = 5–6. …”

Anti-microbial peptide treatment decreases parasitemia levels in <i>P. yoelii</i> 17XNL infected mice. by Marcela Parra (192362)

Characterization of Niphatenones that Inhibit Androgen Receptor N-Terminal Domain by Carmen A. Banuelos (636867)

“…Both enantiomers had similar IC50 values of 6 µM for inhibiting the full-length AR in a functional transcriptional assay. …”

Panobinostat downregulated Ron mRNA, protein expression and decreased downstream signaling through pAkt, XIAP, and survivin. by Yi Zou (439002)

Down regulation of Nrf2 leads to decreased Mrp1 and sensitized H69AR cells to chemotherapeutic drugs. by Lili Ji (296025)

Auditory fear conditioning induced persistent fear memory and decreased the survival of adult-born cells in both the amygdala and hippocampus. by Lizhu Jiang (522719)

PDK1 inhibitor PF-5177624 decreased IGF-I induced AKT and p70S6K phosphorylation. by Sangita M. Baxi (123560)

Geniposide(Gen) significantly decreased the levels of TNF-α and MIP-1α in BALF of bleomycin-induced PF mice. by Jian-Bin Yin (19556105)

iNOS deficiency ameliorated increased expression of atrogenes and decreased cross-sectional area in skeletal muscle of burned mice. by Harumasa Nakazawa (684211)

“…<p>A, B, At 3 days after burn or sham-burn, mRNA levels of atrogenes, Murf1 and atrogin-1, were significantly increased by burn injury in wild-type (WT) mice. …”

Data_Sheet_1_Switching to second line MS disease-modifying therapies is associated with decreased relapse rate.PDF by James John Marriott (16935942)

Analysis of c-Kit immunohistochemistry. by Yong Hwan Kwon (3612245)

Beta-catenin-positive area was decreased after ovariectomy (OVX) and increased after midkine-antibody (Mdk-Ab) treatment. by Melanie Haffner-Luntzer (504724)

Table_1_Endocervical Regulatory T Cells Are Associated With Decreased Genital Inflammation and Lower HIV Target Cell Abundance.xlsx by Aloysious Ssemaganda (792055)

Data_Sheet_1_Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke.pdf by Jin-Yi Hsu (11372153)

Cardiac sympathetic fiber density decreased post-6-OHDA and correlated with <i>in vivo</i> and post mortem markers. by Jeanette M. Metzger (8259900)

Image_1_Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.tif by Jialyu Huang (6742409)

“…</p>Results<p>Each millimeter decrease in EMT was related to a 9% (adjusted OR 1.09, 95% CI 1.00–1.19; P = 0.053), 14% (adjusted OR 1.14, 95% CI 1.02–1.28; P = 0.002) and 22% (adjusted OR 1.22, 95% CI 1.07–1.38; P = 0.003) higher risk of PTB, LBW and SGA, respectively. …”

Image_2_Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.tif by Jialyu Huang (6742409)

“…</p>Results<p>Each millimeter decrease in EMT was related to a 9% (adjusted OR 1.09, 95% CI 1.00–1.19; P = 0.053), 14% (adjusted OR 1.14, 95% CI 1.02–1.28; P = 0.002) and 22% (adjusted OR 1.22, 95% CI 1.07–1.38; P = 0.003) higher risk of PTB, LBW and SGA, respectively. …”

Table_1_Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.docx by Jialyu Huang (6742409)

“…</p>Results<p>Each millimeter decrease in EMT was related to a 9% (adjusted OR 1.09, 95% CI 1.00–1.19; P = 0.053), 14% (adjusted OR 1.14, 95% CI 1.02–1.28; P = 0.002) and 22% (adjusted OR 1.22, 95% CI 1.07–1.38; P = 0.003) higher risk of PTB, LBW and SGA, respectively. …”